Lumexa priced the offering within its target range, achieving a multi-billion-dollar valuation. The company operates in the medical imaging space, a sector that has attracted sustained private equity interest. The listing provides partial liquidity for Welsh Carson, which backed Lumexa during its expansion phase. The IPO comes as sponsors increasingly test equity markets after a prolonged slowdown in exits. Subscribe to our Newsletter to increase your edge. Don't worry about the news anymore, through our newsletter you'll receive weekly access to what is happening. Join 120,000 other PE professionals today.
learn more
